Physician

Sarah Elizabeth Vieta, MD

According to 2025 Medicare claims, Sarah Vieta, MD (NPI: 1386791101) practices dermatology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is VIETA DERMATOLOGY, PLLC (NPI: 1942713052; TIN: 823199701) and primary practice location at 28374-7930.

Vieta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 597 traditional Medicare patients, billed 8,223 HCPCS/CPT codes, and received $688,164 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 653 prescription claims across 355 beneficiaries totaling $19,026 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $229,684 and ending at $688,164. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $26,793 and ending at $19,026. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	492	3,906	$229,684
2016	535	6,284	$580,483
2017	485	4,097	$1,069,969
2018	242	2,386	$206,724
2019	537	8,454	$727,951
2020	593	9,949	$687,367
2021	575	9,942	$743,307
2022	569	9,517	$770,794
2023	647	8,637	$814,926
2024	597	8,223	$688,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	359	$26,793
2016	280	673	$41,201
2017	254	475	$17,325
2018	118	193	$10,799
2019	325	686	$22,948
2020	444	969	$33,462
2021	421	895	$25,193
2022	476	1,026	$28,160
2023	406	757	$17,549
2024	355	653	$19,026

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	477	862	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	475	972	$63
11103	Biopsy of related skin growth, each additional growth	329	912	$37
17000	Destruction of precancer skin growth, 1 growth	395	687	$29
17003	Destruction of precancer skin growth, 2-14 growths	308	2,280	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	36	1,039	$2,195
Ketoconazole	Ketoconazole	94	2,462	$1,772
Clobetasol Propionate	Clobetasol Propionate	27	679	$1,137
Triamcinolone Acetonide	Triamcinolone Acetonide	100	2,423	$710
Mupirocin	Mupirocin	119	2,110	$679

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	Arcutis Biotherapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sarah Elizabeth Vieta, MD?

Tedicare shows public-source Medicare data for Sarah Elizabeth Vieta, MD (NPI 1386791101), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Elizabeth Vieta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Elizabeth Vieta, MD?

Sarah Elizabeth Vieta, MD is linked to VIETA DERMATOLOGY, PLLC (billing NPI 1942713052) in the available physician profile data.

Does Sarah Elizabeth Vieta, MD have Open Payments data?

Sarah Elizabeth Vieta, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.